Our partner is dedicated to developing therapies for neurodegenerative diseases, with a focus on conditions like Alzheimer's and Parkinson's. Their innovative approach targets the underlying protein misfolding and aggregation mechanisms, aiming to improve patient outcomes and quality of life for those with these challenging conditions.

This critical hire provided strategic and operational leadership to ensure clinical trials followed good clinical practices. They were responsible for recruiting, mentoring, and directing internal and external Quality Assurance. In this leadership role, they maintained and expanded working knowledge of applicable FDA, EMA applicable regulations, directives, and guidelines.